Weihong Chen

500 total citations
8 papers, 396 citations indexed

About

Weihong Chen is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Weihong Chen has authored 8 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Weihong Chen's work include CAR-T cell therapy research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Weihong Chen is often cited by papers focused on CAR-T cell therapy research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Weihong Chen collaborates with scholars based in China, United States and Italy. Weihong Chen's co-authors include Riccardo Dalla‐Favera, Kenneth Offit, Caterina Fusco, Stefano Martinotti, Anna Migliazza, D M Knowles, R. S. K. Chaganti, Xiaoqing Li, Honghong Sun and Aifa Tang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Weihong Chen

7 papers receiving 387 citations

Peers

Weihong Chen

PFM

ONCOL

IMMUN

GENET

MB

Sarah Haebe Germany

Sylvia Snauwaert Belgium

Marion Alcantara France

Vadim Dyomin United States

Selda Samakoglu United States

Noelia Purroy Spain

Brenda Verhaaf Netherlands

Patricia Johansson Germany

D M Grote United States

G Wong United States

Sarah Haebe Germany

Weihong Chen

128 ×0.6

PFM

173 ×0.9

ONCOL

119 ×0.8

IMMUN

67 ×0.5

GENET

77 ×0.7

MB

Citations per year, relative to Weihong Chen Weihong Chen (= 1×) peers Sarah Haebe

Countries citing papers authored by Weihong Chen

Since Specialization

Citations

This map shows the geographic impact of Weihong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Chen more than expected).

Fields of papers citing papers by Weihong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Chen. The network helps show where Weihong Chen may publish in the future.

Co-authorship network of co-authors of Weihong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Weihong Chen. A scholar is included among the top collaborators of Weihong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihong Chen. Weihong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Jiao, Cheng, Yuchen Liu, Rui Zhang, Weihong Chen, & Lung‐Ji Chang. (2022). Pro-Active 4SCAR2.0 Therapy with NGS-MRD Disease Monitoring in High-Risk B Cell Leukemia Management. Blood. 140(Supplement 1). 12744–12745.

2.

Chen, Weihong, Xiaochun Wan, Xin Du, et al.. (2022). Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma. Frontiers in Genetics. 12. 815679–815679. 4 indexed citations

3.

Chen, Weihong, et al.. (2022). Follicular lymphoma presenting like marginal zone lymphoma: A case report. World Journal of Clinical Cases. 10(17). 5877–5883. 1 indexed citations

4.

Li, Xiaoqing & Weihong Chen. (2019). Mechanisms of failure of chimeric antigen receptor T-cell therapy. Current Opinion in Hematology. 26(6). 427–433. 27 indexed citations

5.

Yan, Dehong, Jinghui Wang, Honghong Sun, et al.. (2019). TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. The Journal of Experimental Medicine. 217(2). 54 indexed citations

6.

Chen, Weihong, et al.. (2016). Anti-CD19 Chimeric Antigen Receptor T Cells Improve Responses to Chemotherapy-Refractory Mantle Cell Lymphoma: A Case Report. Blood. 128(22). 5393–5393. 5 indexed citations

7.

Chen, Weihong, et al.. (2014). Safety of growth factor administration for leukapheresis in those with WBC counts greater than 60,000/µl. Journal of Clinical Apheresis. 30(1). 28–31. 4 indexed citations

8.

Migliazza, Anna, Stefano Martinotti, Weihong Chen, et al.. (1995). Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma.. Proceedings of the National Academy of Sciences. 92(26). 12520–12524. 301 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact